Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
May 6, 2013 shooter eric m Director Sell 10,000 258.78 - 264.18
May 6, 2013 shooter eric m Director Sell 20,000 256.49 - 264.13
May 6, 2013 aberman michael s Officer Sell 8,334 256.46 - 257.29
May 21, 2013 goldberg murray a Officer Automatic Sell 66,835 255.52 - 264.61
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
May 2, 2013 mccorkle douglas s Officer Automatic Sell 2,213 241.45 - 247.21
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
May 1, 2013 mccorkle douglas s Officer Automatic Sell 3,662 233.53
May 1, 2013 schleifer leonard s Officer Automatic Sell 100,000 225.01 - 250.06
Apr 12, 2013 mccorkle douglas s Officer Automatic Sell 3,129 205.82 - 214.10
Apr 11, 2013 mccorkle douglas s Officer Automatic Sell 2,746 204.57
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Dec 11, 2012 aberman michael s Officer Automatic Sell 3,368 184.85 - 185.18
Dec 10, 2012 aberman michael s Officer Automatic Sell 4,132 182.68
Nov 29, 2012 aberman michael s Officer Automatic Sell 4,430 182.20
Showing 201-220 of 952 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)